Glow
Three-peptide research blend studied in collagen synthesis, cell migration, angiogenic signaling, and extracellular-matrix remodeling models.
$105.00
- FormatLyophilized powder blend, 70mg vial
- Storage-20°C for long-term stability; protect from direct light
Glow is a multi-peptide blend that combines several research compounds in a single 70 mg freeze-dried vial. Its individual components have been studied in skin…
50 in stock
About Glow
Glow is a three-peptide research blend combining BPC-157, TB-500, and GHK-Cu in a 70 mg lyophilized vial. Research on the individual components has examined collagen synthesis, extracellular-matrix remodeling, cell migration, cytoskeletal activity, angiogenic signaling, and dermal and wound-related models. The blend is supplied for researchers investigating multiple tissue and matrix pathways together.
Full Specification
| Molecular Formula | Mixture (BPC-157 + TB-500 + GHK-Cu) |
| Purity | ≥99% (HPLC verified per component) |
| Appearance | Blue Lyophilized Powder |
| Storage | -20°C for long-term stability; protect from direct light |
| Format | Lyophilized powder blend, 70mg vial |
The Glow Molecule
An illustrative representation generated from the compound's molecular formula, alongside its logged molecular data. This figure is schematic — not a measured conformation.
How Glow Works
The pathways Glow acts on — and what each one does. The animation traces its signal outward from the compound to every target it engages.
Signalling pathways studied in preclinical models · illustrative
VEGF Pathway
BPC-157BPC-157 has been studied in preclinical models involving vessel formation, tissue granulation, and nitric oxide signaling.
Actin Regulation
TB-500TB-500, a thymosin beta-4 fragment, has been studied in relation to actin regulation, cell migration, cytoskeletal remodeling, and fibrotic endpoints.
Collagen & ECM Remodeling
GHK-CuGHK-Cu is a copper-binding tripeptide studied in extracellular-matrix models involving Type I and III collagen synthesis, gene expression, and copper delivery to tissue.
What Glow Is Researched For
Dermal Models
GHK-Cu is studied in collagen synthesis models, while BPC-157 and TB-500 have been investigated in epithelial and scarring models.
Cytoskeletal & Vascular
TB-500 is studied for actin remodeling, BPC-157 for tendon fibroblast and vascular-related endpoints, and GHK-Cu for endothelial and matrix activity.
Anti-Inflammatory Models
Research on the three peptide components includes inflammatory endpoints through different mechanisms in animal and cellular models.
ECM Remodeling
The components are studied in relation to extracellular-matrix deposition, collagen activity, tissue structure, and fibrotic scoring.
Study-Reported Magnitudes
Representative figures from published research; results vary by protocol.
Common Questions About Glow
GLOW is a three-peptide research blend containing BPC-157, TB-500, and GHK-Cu in a 70 mg lyophilized vial.
The three components are studied across complementary pathways involving vascular signaling, actin and cell migration, collagen synthesis, and extracellular-matrix remodeling.
GLOW is supplied as a research-use-only peptide blend. The supplied source does not provide evidence of FDA approval.
The supplied specification recommends storage at -20°C for long-term stability and protection from direct light.
Each batch is described as undergoing third-party HPLC purity analysis, mass spectrometry, heavy-metal screening, endotoxin testing, sterility testing, and net peptide content testing.
Research on the individual components includes preclinical and cellular studies involving collagen synthesis, cell migration, angiogenic signaling, cytoskeletal remodeling, wound-related models, and extracellular-matrix activity.